{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:56:49Z","timestamp":1792616209310,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jinf.2026.106863","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:55:26Z","timestamp":1790175326000},"page":"106863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Host immune biomarkers associated with infection risk after CAR T-cell therapy"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-3592","authenticated-orcid":false,"given":"Gemma K.","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4808-9580","authenticated-orcid":false,"given":"Lewis","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goknur","family":"Giner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8312-8450","authenticated-orcid":false,"given":"Alex","family":"Garnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therease","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7357-2024","authenticated-orcid":false,"given":"Adrian","family":"Minson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4250-4448","authenticated-orcid":false,"given":"Lynette","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1492-5966","authenticated-orcid":false,"given":"Michael","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Thursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Oliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica A.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Doerflinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin W.","family":"Teh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2026.106863_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104134","article-title":"Infections in haematology patients treated with CAR-T therapies: a systematic review and meta-analysis","volume":"192","author":"Reynolds","year":"2023","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.jinf.2026.106863_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2023.05.011","article-title":"Predicting infections in patients with haematological malignancies treated with chimeric antigen receptor T-cell therapies: a systematic scoping review and narrative synthesis","author":"Reynolds","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.jinf.2026.106863_bib3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3324\/haematol.2019.238634","article-title":"Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma","volume":"106","author":"Logue","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jinf.2026.106863_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2024.07.018","article-title":"Best practice considerations by the American society of transplant and cellular therapy: infection prevention and management after chimeric antigen receptor t cell therapy for hematological malignancies","author":"Shahid","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jinf.2026.106863_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.70049","article-title":"Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia","volume":"14","author":"Williams","year":"2025","journal-title":"Clin Transl Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2026.106863_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1235","article-title":"Successful identification of predictive profiles for infection utilising systems-level immune analysis: a pilot study in patients with relapsed and refractory multiple myeloma","volume":"10","author":"Doerflinger","year":"2021","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.jinf.2026.106863_bib7","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3389\/fimmu.2017.01247","article-title":"Predicting risk of infection in patients with newly diagnosed multiple myeloma: utility of immune profiling","volume":"8","author":"Teh","year":"2017","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jinf.2026.106863_bib8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2026.106863_bib9","doi-asserted-by":"crossref","unstructured":"Kr\u00f6ger N., Gribben J., Chabannon C., et al The EBMT\/EHA CAR-T Cell Handbook. 2022.","DOI":"10.1007\/978-3-030-94353-0"},{"issue":"10","key":"10.1016\/j.jinf.2026.106863_bib10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood.2023020578","article-title":"Immune effector cell\u2013associated hematotoxicity: EHA\/EBMT consensus grading and best practice recommendations","volume":"142","author":"Rejeski","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2026.106863_bib11","unstructured":"Teh B.W., Mikulska M., Averbuch D., et al. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients. The Lancet Infectious Diseases."},{"issue":"7","key":"10.1016\/j.jinf.2026.106863_bib14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.jinf.2026.106863_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2010-11-3-r25","article-title":"A scaling normalization method for differential expression analysis of RNA-seq data","volume":"11","author":"Robinson","year":"2010","journal-title":"Genome Biol"},{"issue":"7","key":"10.1016\/j.jinf.2026.106863_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1-2","key":"10.1016\/j.jinf.2026.106863_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","article-title":"Controlling the false discovery rate in behavior genetics research","volume":"125","author":"Benjamini","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jinf.2026.106863_bib18","doi-asserted-by":"crossref","first-page":"D277","DOI":"10.1093\/nar\/gkh063","article-title":"The KEGG resource for deciphering the genome","volume":"32","author":"Kanehisa","year":"2004","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.jinf.2026.106863_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.jinf.2026.106863_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae133","article-title":"The burden of invasive fungal disease following CAR T-cell therapy and strategies for prevention","author":"Little","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2026.106863_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004475","article-title":"The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R\/R LBCL","volume":"10","author":"Rejeski","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"9","key":"10.1016\/j.jinf.2026.106863_bib22","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3390\/cancers15092411","article-title":"Long-term host immune modulation following tisagenlecleucel administration in patients with diffuse large B-Cell lymphoma and b-lineage acute lymphoblastic leukemia","volume":"15","author":"Guarini","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.jinf.2026.106863_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000858","article-title":"Identifying early infections in the setting of CRS with routine and exploratory serum proteomics and the HT10 score following CD19 CAR-T for relapsed\/refractory B-NHL","volume":"7","author":"Rejeski","year":"2023","journal-title":"Hemasphere"},{"issue":"2","key":"10.1016\/j.jinf.2026.106863_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.clim.2013.04.014","article-title":"Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells","volume":"148","author":"Jenks","year":"2013","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.jinf.2026.106863_bib25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.semcdb.2008.07.011","article-title":"New insights into the roles of Stat5a\/b and Stat3 in T cell developmen t and differentiation","volume":"19","author":"Wei","year":"2008","journal-title":"Semin Cell amp Dev Biol"},{"issue":"4","key":"10.1016\/j.jinf.2026.106863_bib26","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4049\/jimmunol.167.4.1962","article-title":"Impairment in the expression and activity of fyn during differentiatio n of naive CD4+ T cells into the Th2 Subset","volume":"167","author":"Tamura","year":"2001","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.jinf.2026.106863_bib27","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.190.8.1189","article-title":"The src family tyrosine kinase fyn regulates natural killer T cell development","volume":"190","author":"Gadue","year":"1999","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jinf.2026.106863_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s40364-024-00693-8","article-title":"A pair of promising immune checkpoints PSGL-1 and VISTA from immunotolerance to immunotherapy","volume":"12","author":"Peng","year":"2024","journal-title":"Biomark Res"},{"issue":"1","key":"10.1016\/j.jinf.2026.106863_bib29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/imr.13195","article-title":"Human fetal T cells: insights into developmental specialization and mechanisms of lineage transition","volume":"315","author":"Burt","year":"2023","journal-title":"Immunol Rev"},{"issue":"41","key":"10.1016\/j.jinf.2026.106863_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav5947","article-title":"Helios enhances the preferential differentiation of human fetal CD4+ na\u00efve T cells into regulatory T cells","volume":"4","author":"Ng","year":"2019","journal-title":"Sci Immunol"},{"issue":"5","key":"10.1016\/j.jinf.2026.106863_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040176","article-title":"Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma","volume":"4","author":"Critchley-Thorne","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2026.106863_bib32","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2018.02569","article-title":"T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses","volume":"9","author":"Saeidi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2026.106863_bib33","article-title":"Identification and immunoassay of biomarkers associated with T cell exhaustion in systemic lupus erythematosus","volume":"16","author":"Zheng","year":"2025","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2026.106863_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12964-022-00856-w","article-title":"A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)","volume":"20","author":"Mohammed","year":"2022","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jinf.2026.106863_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1034257","article-title":"Mechanisms of CAR T cell exhaustion and current counteraction strategies","volume":"10","author":"Zhu","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"10.1016\/j.jinf.2026.106863_bib36","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/s41590-023-01659-y","article-title":"Forks in the road for CAR T and CAR NK cell cancer therapies","volume":"24","author":"Dagher","year":"2023","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.jinf.2026.106863_bib37","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.4049\/jimmunol.1301389","article-title":"Transcriptional regulation of IL-15 expression during hematopoiesis","volume":"191","author":"Colpitts","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2026.106863_bib38","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3389\/fimmu.2018.01012","article-title":"Immune modulation by human secreted RNases at the extracellular space","volume":"9","author":"Lu","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jinf.2026.106863_bib39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCRESAHA.115.307961","article-title":"Extracellular ribonucleic acids (RNA) enter the stage in cardiovascular disease","volume":"118","author":"Zernecke","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jinf.2026.106863_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biopha.2017.02.094","article-title":"Ribonuclease attenuates hepatic ischemia reperfusion induced cognitive impairment through the inhibition of inflammatory cytokines in aged mice","volume":"90","author":"Ma","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jinf.2026.106863_bib41","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fimmu.2024.1450173","article-title":"Identification of early predictive biomarkers for severe cytokine release syndrome in pediatric patients with chimeric antigen receptor T-cell therapy","volume":"15","author":"Su","year":"2024","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2026.106863_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","article-title":"Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy","volume":"22","author":"Morris","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.jinf.2026.106863_bib43","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1158\/2159-8290.CD-17-0698","article-title":"Endothelial activation and blood\u2013brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells","volume":"7","author":"Gust","year":"2017","journal-title":"Cancer Discov"},{"issue":"21","key":"10.1016\/j.jinf.2026.106863_bib44","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/blood-2017-06-793141","article-title":"Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor\u2013modified T-cell therapy","volume":"130","author":"Hay","year":"2017","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jinf.2026.106863_bib45","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1158\/2159-8290.CD-17-1319","article-title":"Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemiabiomarkers of neurotoxicity in CD19 CAR T cell therapy","volume":"8","author":"Santomasso","year":"2018","journal-title":"Cancer Discov"},{"issue":"26","key":"10.1016\/j.jinf.2026.106863_bib46","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"New Engl J Med"},{"issue":"9","key":"10.1016\/j.jinf.2026.106863_bib47","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","article-title":"The biology of TREM receptors","volume":"23","author":"Colonna","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2026.106863_bib48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1746-1596-8-24","article-title":"Triggering receptor expressed on myeloid cells\u2009\u2212\u20091 (Trem-1) on blood neutrophils is associated with cytokine inducibility in human E. coli sepsis","volume":"8","author":"van Bremen","year":"2013","journal-title":"Diagn Pathol"},{"issue":"11","key":"10.1016\/j.jinf.2026.106863_bib49","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3390\/diagnostics11111979","article-title":"The prognostic value of serum soluble TREM-1 on outcome in adult patients with sepsis","volume":"11","author":"Kung","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.jinf.2026.106863_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.907387","article-title":"TREM-1 modulation strategies for sepsis","volume":"13","author":"Siskind","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2026.106863_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13054-024-04798-2","article-title":"Triggering receptor expressed on myeloid cells-1 in sepsis, and current insights into clinical studies","volume":"28","author":"Theobald","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.jinf.2026.106863_bib52","series-title":"C56. SEPSIS: FROM BENCH TO THE BEDSIDE","first-page":"A4704","article-title":"sTREM-1 (Soluble Triggering Receptor Expressed on Myeloid Cells-1) as Marker Indicating Infection in Patients with Neutropenic Fever","author":"Lin","year":"2009"},{"key":"10.1016\/j.jinf.2026.106863_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2015.00079","article-title":"Targeting TREM-1 Signaling in the Presence of Antibiotics is Effective Against Streptococcal Toxic-Shock-Like Syndrome (STSLS) Caused by Streptococcus suis","volume":"5","author":"Yang","year":"2015","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.jinf.2026.106863_bib54","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/21505594.2021.1879471","article-title":"TREM1 regulates antifungal immune responses in invasive pulmonary aspergillosis","volume":"12","author":"Bernal-Martinez","year":"2021","journal-title":"Virulence"},{"issue":"3","key":"10.1016\/j.jinf.2026.106863_bib55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00251-022-01280-7","article-title":"Genetic variation of glycophorins and infectious disease","volume":"75","author":"Hollox","year":"2023","journal-title":"Immunogenetics"},{"issue":"3","key":"10.1016\/j.jinf.2026.106863_bib56","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/CMR.00109-14","article-title":"Blood Groups in Infection and Host Susceptibility","volume":"28","author":"Cooling","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.jinf.2026.106863_bib57","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/glycob\/9.8.747","article-title":"Evolutionary considerations in relating oligosaccharide diversity to biological function","volume":"9","author":"Gagneux","year":"1999","journal-title":"Glycobiology"},{"key":"10.1016\/j.jinf.2026.106863_bib58","article-title":"CD71+ Erythroid Cell Expansion in Adult Sepsis: Potential Causes and Role in Prognosis and Nosocomial Infection Prediction","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jinf.2026.106863_bib59","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/JLB.5MA0721-825R","article-title":"Dynamic changes in human single-cell transcriptional signatures during fatal sepsis","volume":"110","author":"Qiu","year":"2021","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.jinf.2026.106863_bib60","article-title":"Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies","volume":"25","author":"Kampouri","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jinf.2026.106863_bib61","article-title":"Monocyte chemoattractant protein-1 as a potential marker for patients with sepsis: a systematic review and meta-analysis","volume":"10","author":"Chen","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"ement 1","key":"10.1016\/j.jinf.2026.106863_bib62","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1182\/blood-2019-129421","article-title":"Impact of bridging chemotherapy on clinical outcomes of CD19 CAR T therapy in relapse\/refractory diffuse large B- cell lymphoma in real world experience","volume":"134","author":"Paillassa","year":"2019","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.jinf.2026.106863_bib63","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010356","article-title":"Early plasma monocyte chemoattractant protein 1 predicts the development of sepsis in trauma patients: a prospective observational study","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine"},{"issue":"ement 1","key":"10.1016\/j.jinf.2026.106863_bib64","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood-2019-125162","article-title":"Impact and safety of chimeric antigen receptor T cell therapy in vulnerable older patients with relapsed\/refractory diffuse large B-cell lymphoma","volume":"134","author":"Lin","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2026.106863_bib65","first-page":"193","article-title":"Patient characteristics and pre-infusion biomarkers of inflammation correlate with clinical outcomes after treatment with the defined composition, CD19-targeted CAR T cell product, JCAR017","volume":"130","author":"Siddiqi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2026.106863_bib66","first-page":"24","article-title":"Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?","volume":"30","author":"Behar","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jinf.2026.106863_bib67","article-title":"Innate immune signaling and susceptibility to bacterial pneumonia during TNF-targeted therapy","volume":"12","author":"Jutras","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jinf.2026.106863_bib68","first-page":"1643","article-title":"TNF signalling in health and disease","volume":"11","author":"Silke","year":"2020","journal-title":"Front Microbiol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445326001891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445326001891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:27:14Z","timestamp":1792614434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445326001891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0163445326001891"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106863","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host immune biomarkers associated with infection risk after CAR T-cell therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106863","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106863"}}